Microfluidic Chip-Based Cancer Diagnosis and Prediction of Relapse by Detecting Circulating Tumor Cells and Circulating Cancer Stem Cells

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2021 Apr 3

PMID 33803846

Citations 10

Authors

Hyeon-Yeol Cho

Jin-Ha Choi

Joungpyo Lim

Sang-Nam Lee

Jeong-Woo Choi

Affiliations

Soon will be listed here.

Abstract

Detecting circulating tumor cells (CTCs) has been considered one of the best biomarkers in liquid biopsy for early diagnosis and prognosis monitoring in cancer. A major challenge of using CTCs is detecting extremely low-concentrated targets in the presence of high noise factors such as serum and hematopoietic cells. This review provides a selective overview of the recent progress in the design of microfluidic devices with optical sensing tools and their application in the detection and analysis of CTCs and their small malignant subset, circulating cancer stem cells (CCSCs). Moreover, discussion of novel strategies to analyze the differentiation of circulating cancer stem cells will contribute to an understanding of metastatic cancer, which can help clinicians to make a better assessment. We believe that the topic discussed in this review can provide brief guideline for the development of microfluidic-based optical biosensors in cancer prognosis monitoring and clinical applications.

Citing Articles

Nanomaterial-based detection of circulating tumor cells and circulating cancer stem cells for cancer immunotherapy.

Yun Y, Kim S, Lee S, Cho H, Choi J Nano Converg. 2024; 11(1):56.

PMID: 39671082 PMC: 11645384. DOI: 10.1186/s40580-024-00466-x.

Microfluidic Applications in Prostate Cancer Research.

Szewczyk K, Jiang L, Khawaja H, Miranti C, Zohar Y Micromachines (Basel). 2024; 15(10).

PMID: 39459070 PMC: 11509716. DOI: 10.3390/mi15101195.

Optical nanomaterial-based detection of biomarkers in liquid biopsy.

Kim Y, Rho W, Park S, Jun B J Hematol Oncol. 2024; 17(1):10.

PMID: 38486294 PMC: 10938695. DOI: 10.1186/s13045-024-01531-y.

Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors.

Capuozzo M, Ferrara F, Santorsola M, Zovi A, Ottaiano A Cells. 2023; 12(22).

PMID: 37998325 PMC: 10670669. DOI: 10.3390/cells12222590.

Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges.

Kong A, Wu A, Ho O, Leung M, Huang A, Yu Y Int J Mol Sci. 2023; 24(14).

PMID: 37511539 PMC: 10380291. DOI: 10.3390/ijms241411780.

References

Cohen S, Punt C, Iannotti N, Saidman B, Sabbath K, Gabrail N . Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol. 2009; 20(7):1223-9. DOI: 10.1093/annonc/mdn786. View

Tayoun T, Faugeroux V, Oulhen M, Aberlenc A, Pawlikowska P, Farace F . CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs). Cells. 2019; 8(10). PMC: 6829286. DOI: 10.3390/cells8101145. View

Medley C, Smith J, Tang Z, Wu Y, Bamrungsap S, Tan W . Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Anal Chem. 2008; 80(4):1067-72. DOI: 10.1021/ac702037y. View

Gallo M, De Luca A, Maiello M, DAlessio A, Esposito C, Chicchinelli N . Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer. Transl Lung Cancer Res. 2017; 6(4):486-498. PMC: 5583074. DOI: 10.21037/tlcr.2017.05.07. View

Chang Z, Wang Z, Shao D, Yue J, Xing H, Li L . Shape Engineering Boosts Magnetic Mesoporous Silica Nanoparticle-Based Isolation and Detection of Circulating Tumor Cells. ACS Appl Mater Interfaces. 2018; 10(13):10656-10663. DOI: 10.1021/acsami.7b19325. View

Hyun K, Koo G, Han H, Sohn J, Choi W, Kim S . Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer. Oncotarget. 2016; 7(17):24677-87. PMC: 5029733. DOI: 10.18632/oncotarget.8250. View

Pantel K, Alix-Panabieres C . Liquid biopsy and minimal residual disease - latest advances and implications for cure. Nat Rev Clin Oncol. 2019; 16(7):409-424. DOI: 10.1038/s41571-019-0187-3. View

Mathivanan S, Ji H, Simpson R . Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010; 73(10):1907-20. DOI: 10.1016/j.jprot.2010.06.006. View

Lee H, Cho H, Oh J, Namkoong K, Lee J, Park J . Simultaneous capture and in situ analysis of circulating tumor cells using multiple hybrid nanoparticles. Biosens Bioelectron. 2013; 47:508-14. DOI: 10.1016/j.bios.2013.03.040. View

10.

Takaishi S, Okumura T, Tu S, Wang S, Shibata W, Vigneshwaran R . Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009; 27(5):1006-20. PMC: 2746367. DOI: 10.1002/stem.30. View

11.

Cho Y, Park J, Lee K, Lee T, Luo Z, Kim T . Recent advances in nanomaterial-modified electrical platforms for the detection of dopamine in living cells. Nano Converg. 2020; 7(1):40. PMC: 7755953. DOI: 10.1186/s40580-020-00250-7. View

12.

Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A . Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res. 2005; 11(10):3678-85. DOI: 10.1158/1078-0432.CCR-04-2469. View

13.

Jin M, Jin W . The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020; 5(1):166. PMC: 7447642. DOI: 10.1038/s41392-020-00280-x. View

14.

Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

15.

Zhang X, Shi S, Zhang B, Ni Q, Yu X, Xu J . Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes. Am J Cancer Res. 2018; 8(3):332-353. PMC: 5883088. View

16.

Court C, Hou S, Winograd P, Segel N, Li Q, Zhu Y . A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma. Liver Transpl. 2018; 24(7):946-960. PMC: 6097911. DOI: 10.1002/lt.25062. View

17.

Nie L, Li F, Huang X, Aguilar Z, Wang Y, Xiong Y . Folic Acid Targeting for Efficient Isolation and Detection of Ovarian Cancer CTCs from Human Whole Blood Based on Two-Step Binding Strategy. ACS Appl Mater Interfaces. 2018; 10(16):14055-14062. DOI: 10.1021/acsami.8b02583. View

18.

Sierra J, Marrugo-Ramirez J, Rodriguez-Trujillo R, Mir M, Samitier J . Sensor-Integrated Microfluidic Approaches for Liquid Biopsies Applications in Early Detection of Cancer. Sensors (Basel). 2020; 20(5). PMC: 7085501. DOI: 10.3390/s20051317. View

19.

Nagrath S, Sequist L, Maheswaran S, Bell D, Irimia D, Ulkus L . Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007; 450(7173):1235-9. PMC: 3090667. DOI: 10.1038/nature06385. View

20.

Liu W, Wei H, Lin Z, Mao S, Lin J . Rare cell chemiluminescence detection based on aptamer-specific capture in microfluidic channels. Biosens Bioelectron. 2011; 28(1):438-42. DOI: 10.1016/j.bios.2011.07.067. View